- $108.98bn
- $180.09bn
- $15.20bn
- 52
- 27
- 81
- 52
2019 December 31st | 2020 December 31st | R2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 4,562 | 4,530 | 16,918 | 6,663 | 15,204 |
Cost of Revenue | |||||
Gross Profit | 4,221 | 4,231 | 11,252 | 3,068 | 7,456 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 3,249 | 3,233 | 11,907 | 6,957 | 13,063 |
Operating Profit | 1,312 | 1,298 | 5,012 | -294 | 2,141 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 5,168 | 5,727 | 13,847 | -292 | 6,555 |
Provision for Income Taxes | |||||
Net Income After Taxes | 4,640 | 5,118 | 12,452 | -418 | 5,357 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 2,005 | 2,003 | 4,732 | -522 | 3,732 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 1,972 | 1,946 | 4,627 | -591 | 3,681 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 3.54 | 3.33 | 7.27 | -0.738 | 4.21 |
Dividends per Share |